莫西沙星序贯疗法治疗社区获得性肺炎疗效分析  

Analysis on therapeutic effect of sequential therapy of moxifloxacin in the treatment of community-acquired pneumonia

作　　者：程志舫[1] 乜庆荣[1] 

机构地区：[1]北京市房山区良乡医院,北京102401

出　　处：《中国药物应用与监测》2008年第3期17-19,共3页Chinese Journal of Drug Application and Monitoring

摘　　要：目的:评价莫西沙星序贯疗法治疗社区获得性肺炎的疗效。方法:对42例社区获得性肺炎(CAP)患者,采用莫西沙星治疗,静点0.4g·d-1,持续3～5d,继之口服0.4g·d-1,维持5～7d。结果:痊愈29例(69%),显效10例(23.8%),有效率92.8%,细菌消除率87.1%,总疗程8～12d,药物副作用较小。结论:莫西沙星序贯疗法治疗社区获得性肺炎疗效高,毒副作用小,疗程较短。Objective： To appraise the therapeutic effect of moxifloxacin on community-acquired pneumonia. Methods： 42 cases of acute community-acquired pneumonia patients were analyzed. Moxifloxacin was intravenous dripped by 0.4 g·d^-1 for 3 to 5 days, then was taken orally by 0.4 g·d^-1 for 5 to 7 days. Results： 29 cases （69%） were cured, and 10 cases （23.8%） were mended, the effective rate was 92.8% and the bacterial eradication rate was 87.1%.The total period of treatment was 8 to 12 days, and the side-effect was slight. Conclusion： The curative effect of the sequential therapy of moxifloxacin on community-acquired pneumonia was high, the side-effect was slight and the period of treatment was short.

关 键 词：莫西沙星 序贯疗法 社区获得性肺炎 

分 类 号：R563.1[医药卫生—呼吸系统]